GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Total Long-Term Assets

DuoGenic StemCells (ROCO:7607) Total Long-Term Assets : NT$22.05 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is DuoGenic StemCells Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. DuoGenic StemCells's Total Long-Term Assets for the quarter that ended in Dec. 2024 was NT$22.05 Mil.

DuoGenic StemCells Total Long-Term Assets Historical Data

The historical data trend for DuoGenic StemCells's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuoGenic StemCells Total Long-Term Assets Chart

DuoGenic StemCells Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Total Long-Term Assets
17.19 27.73 27.31 22.05

DuoGenic StemCells Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Long-Term Assets Get a 7-Day Free Trial 27.73 28.30 27.31 26.43 22.05

DuoGenic StemCells Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

DuoGenic StemCells Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of DuoGenic StemCells's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

DuoGenic StemCells Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Total Long-Term Assets
Comparable Companies
ROCO:6876 ROCO:4170 ROCO:4197 ROCO:6827 ROCO:6744 ROCO:6549 ROCO:6848 ROCO:6917 ROCO:3205 ROCO:6999 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Room R207, Innovation Incubation Center, 145, Xingda Road, South District, Taichung, TWN
Website
https://www.dgsc.com.tw
DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.

DuoGenic StemCells Headlines

No Headlines